Osaka, Japan

Masato Higashino

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Masato Higashino: Innovator in Trk-Inhibiting Compounds

Introduction

Masato Higashino is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit Trk-related diseases. With a total of 9 patents to his name, Higashino's work is paving the way for new therapeutic options.

Latest Patents

Higashino's latest patents focus on Trk-inhibiting compounds that serve as potential treatments for various Trk-related diseases. One of his notable inventions is a drug containing a compound with Trk-inhibiting activity, aimed at treating conditions such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease, and Chagas disease. This compound is represented by a general formula and includes various forms such as salts, N-oxides, solvates, or prodrugs. Another significant patent involves an acid-addition salt of a Trk-inhibiting compound, which selectively inhibits NGF vascular hyper permeability. This compound is designed to be effective without drug interactions and boasts excellent solubility and absorbability.

Career Highlights

Masato Higashino is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential impact on treating complex diseases.

Collaborations

Higashino collaborates with esteemed colleagues, including Jun Takeuchi and Masahiro Ikura, to advance research and development in his field.

Conclusion

Masato Higashino's contributions to the development of Trk-inhibiting compounds highlight his role as a key innovator in the pharmaceutical industry. His work not only showcases his expertise but also promises to improve therapeutic options for patients suffering from various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…